CDKN2B-AS1 and melanoma: To explore whether MTAP-ANRIL could bind to the cytoskeleton of melanoma cells, the effect of MTAP-ANRIL on F-actin cytoskeletal arrangement was assessed by immunofluorescence microscopy.